Centre Eugène Marquis
- Address
- Avenue de la Bataille de Flandres Dunkerque, 35000 Rennes, France
Centre Eugène Marquis - Cancer Research Center
Centre Eugène Marquis is a comprehensive cancer research institution conducting cutting-edge clinical trials across multiple oncology specialties. The center demonstrates particular expertise in early-phase drug development and advanced solid tumor therapeutics, with a strong focus on personalized medicine approaches and innovative treatment combinations.
- Advanced and metastatic solid tumors, including breast cancer with targeted hormone receptor-positive, HER2-negative therapies
- Pediatric oncology specializing in high-risk neuroblastoma and rhabdomyosarcoma treatment protocols
- Novel therapeutic agents including MAT2A inhibitors, CDK4/6 inhibitors, and immunotherapy combinations
- Hematological malignancies and first-in-human studies for relapsed/refractory cancers
The center participates in international collaborative networks such as SIOP-Europa-Neuroblastoma and conducts complex multi-arm trials evaluating chemotherapy regimens, radiotherapy strategies, and maintenance therapies. Their research portfolio spans from dose-finding Phase I studies to large-scale Phase III randomized trials, demonstrating capability in both early drug development and definitive efficacy studies across pediatric and adult populations with various cancer types.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 6 by active trials.
lock +5 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Eugène Marquis
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Irinotecan, Ifosfamide, Vincristine, and Dactinomycin in Frontline and Relapsed Rhabdomyosarcoma in Pediatric and Adult Populations | The University Of Birmingham | Phase I | Recruiting | Oct 2020 | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Carboplatin | 2 | Unknown | 2024-11-21 | 2024-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.